• Complex
  • Title
  • Keyword
  • Abstract
  • Scholars
  • Journal
  • ISSN
  • Conference
成果搜索
High Impact Results & Cited Count Trend for Year Keyword Cloud and Partner Relationship

Query:

学者姓名:罗上益

Refining:

Year

Submit Unfold

Type

Submit Unfold

Indexed by

Submit Unfold

Source

Submit Unfold

Complex

Submit Unfold

Former Name

Submit

Language

Submit

Clean All

Sort by:
Default
  • Default
  • Title
  • Year
  • WOS Cited Count
  • Impact factor
  • Ascending
  • Descending
< Page ,Total 1 >
Integrated Analysis of scRNA-Seq and Bulk RNA-Seq Reveals Metabolic Reprogramming of Liver Cancer and Establishes a Prognostic Risk Model SCIE
期刊论文 | 2024 , 15 (6) | GENES
Abstract&Keyword Cite Version(1)

Abstract :

Liver cancer manifests as a profoundly heterogeneous malignancy, posing significant challenges in terms of both therapeutic intervention and prognostic evaluation. Given that the liver is the largest metabolic organ, a prognostic risk model grounded in single-cell transcriptome analysis and a metabolic perspective can facilitate precise prevention and treatment strategies for liver cancer. Hence, we identified 11 cell types in a scRNA-seq profile comprising 105,829 cells and found that the metabolic activity of malignant cells increased significantly. Subsequently, a prognostic risk model incorporating tumor heterogeneity, cell interactions, tumor cell metabolism, and differentially expressed genes was established based on eight genes; this model can accurately distinguish the survival outcomes of liver cancer patients and predict the response to immunotherapy. Analyzing the immune status and drug sensitivity of the high- and low-risk groups identified by the model revealed that the high-risk group had more active immune cell status and greater expression of immune checkpoints, indicating potential risks associated with liver cancer-targeted drugs. In summary, this study provides direct evidence for the stratification and precise treatment of liver cancer patients, and is an important step in establishing reliable predictors of treatment efficacy in liver cancer patients.

Keyword :

liver cancer liver cancer metabolic reprogramming metabolic reprogramming prognostic risk model prognostic risk model single-cell RNA-seq single-cell RNA-seq

Cite:

Copy from the list or Export to your reference management。

GB/T 7714 Xiong, Zhuang , Li, Lizhi , Wang, Guoliang et al. Integrated Analysis of scRNA-Seq and Bulk RNA-Seq Reveals Metabolic Reprogramming of Liver Cancer and Establishes a Prognostic Risk Model [J]. | GENES , 2024 , 15 (6) .
MLA Xiong, Zhuang et al. "Integrated Analysis of scRNA-Seq and Bulk RNA-Seq Reveals Metabolic Reprogramming of Liver Cancer and Establishes a Prognostic Risk Model" . | GENES 15 . 6 (2024) .
APA Xiong, Zhuang , Li, Lizhi , Wang, Guoliang , Guo, Lei , Luo, Shangyi , Liao, Xiangwen et al. Integrated Analysis of scRNA-Seq and Bulk RNA-Seq Reveals Metabolic Reprogramming of Liver Cancer and Establishes a Prognostic Risk Model . | GENES , 2024 , 15 (6) .
Export to NoteExpress RIS BibTex

Version :

Integrated Analysis of scRNA-Seq and Bulk RNA-Seq Reveals Metabolic Reprogramming of Liver Cancer and Establishes a Prognostic Risk Model Scopus
期刊论文 | 2024 , 15 (6) | Genes
10| 20| 50 per page
< Page ,Total 1 >

Export

Results:

Selected

to

Format:
Online/Total:41/10137445
Address:FZU Library(No.2 Xuyuan Road, Fuzhou, Fujian, PRC Post Code:350116) Contact Us:0591-22865326
Copyright:FZU Library Technical Support:Beijing Aegean Software Co., Ltd. 闽ICP备05005463号-1